Cerebral Amyloid Angiopathy: Clinicopathologic Features and Pathogenesis

[1]  H. Vinters,et al.  Neuropathologic analysis of hematomas evacuated from patients with spontaneous intracerebral hemorrhage , 2014, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  Maja A. A. Binnewijzend,et al.  Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease , 2013, Neurobiology of Aging.

[3]  E. Eugenin,et al.  Methamphetamine alters blood brain barrier protein expression in mice, facilitating central nervous system infection by neurotropic Cryptococcus neoformans. , 2013, The Journal of infectious diseases.

[4]  J. Baron,et al.  Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy , 2013, Neurology.

[5]  P. Hof,et al.  The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.

[6]  Brian J. Bacskai,et al.  Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models , 2013, Acta Neuropathologica.

[7]  H. Vinters,et al.  A Shift in Microglial β‐Amyloid Binding in Alzheimer's Disease Is Associated with Cerebral Amyloid Angiopathy , 2013, Brain pathology.

[8]  Yi-lin Sun,et al.  The incidence of cerebral amyloid angiopathy in surgically treated intracranial hemorrhage in the Chinese population , 2013, Neurosurgical Review.

[9]  Antonio Colombo,et al.  Anti–amyloid β autoantibodies in cerebral amyloid angiopathy–related inflammation: Implications for amyloid‐modifying therapies , 2013, Annals of neurology.

[10]  M. Colado,et al.  A study on the effect of JNK inhibitor, SP600125, on the disruption of blood–brain barrier induced by methamphetamine , 2013, Neurobiology of Disease.

[11]  C. Iadecola,et al.  Brain and Circulating Levels of A&bgr;1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain , 2013, Stroke.

[12]  M. Toborek,et al.  Infection of human pericytes by HIV-1 disrupts the integrity of the blood–brain barrier , 2012, Journal of cellular and molecular medicine.

[13]  L. Grinberg,et al.  Cerebral amyloid angiopathy impact on endothelium , 2012, Experimental Gerontology.

[14]  Bojana Stefanovic,et al.  Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. , 2012, Brain : a journal of neurology.

[15]  S. Masino,et al.  Ketone bodies protection against HIV‐1 Tat‐induced neurotoxicity , 2012, Journal of neurochemistry.

[16]  J. Geiger,et al.  Role of endolysosomes in HIV-1 Tat-induced neurotoxicity , 2012, ASN neuro.

[17]  À. Rovira,et al.  MMP‐2/MMP‐9 Plasma Level and Brain Expression in Cerebral Amyloid Angiopathy‐Associated Hemorrhagic Stroke , 2012, Brain pathology.

[18]  D. Strayer,et al.  Blood-Brain Barrier Abnormalities Caused by HIV-1 gp120: Mechanistic and Therapeutic Implications , 2012, TheScientificWorldJournal.

[19]  H. Weiner,et al.  Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model , 2012, Neurobiology of Aging.

[20]  L. Cortellini,et al.  Genetic variation at CR1 increases risk of cerebral amyloid angiopathy , 2012, Neurology.

[21]  Colin Smith,et al.  The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  M. Frosch,et al.  Differential recognition of vascular and parenchymal beta amyloid deposition , 2011, Neurobiology of Aging.

[23]  Guoku Hu,et al.  Platelet-Derived Growth Factor B Chain Is a Novel Target Gene of Cocaine-Mediated Notch1 Signaling: Implications for HIV-Associated Neurological Disorders , 2011, The Journal of Neuroscience.

[24]  C. Sudlow,et al.  Genetic associations with brain microbleeds , 2011, Neurology.

[25]  H. Vinters Inflammation Complicates an ‘Age-Related’ Cerebral Microangiopathy , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[26]  A. Easton,et al.  Amyloid β-related Angiitis of the Central Nervous System: Report of 3 Cases , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[27]  J. Clements,et al.  Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood–Brain Barrier Integrity by a Gap Junction-Dependent Mechanism , 2011, The Journal of Neuroscience.

[28]  Honghong Yao,et al.  Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular Permeability , 2011, PloS one.

[29]  Susan Morgello,et al.  Cocaine Hijacks σ1 Receptor to Initiate Induction of Activated Leukocyte Cell Adhesion Molecule: Implication for Increased Monocyte Adhesion and Migration in the CNS , 2011, The Journal of Neuroscience.

[30]  S. Love,et al.  Neprilysin Protects against Cerebral Amyloid Angiopathy and Aβ‐Induced Degeneration of Cerebrovascular Smooth Muscle Cells , 2011, Brain pathology.

[31]  Honghong Yao,et al.  HIV-1 Tat-Mediated Induction of Platelet-Derived Growth Factor in Astrocytes: Role of Early Growth Response Gene 1 , 2011, The Journal of Immunology.

[32]  D. Holtzman,et al.  Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.

[33]  S. Leurgans,et al.  Cerebral amyloid angiopathy pathology and cognitive domains in older persons , 2011, Annals of neurology.

[34]  C. Cordonnier Brain microbleeds: more evidence, but still a clinical dilemma. , 2011, Current opinion in neurology.

[35]  M. Churchill,et al.  Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia , 2011, Journal of NeuroVirology.

[36]  J. Attems,et al.  Capillary CAA and perivascular Aβ-deposition: Two distinct features of Alzheimer's disease pathology , 2010, Journal of the Neurological Sciences.

[37]  H. Vinters,et al.  Aquaporin Expression in the Brains of Patients With or Without Cerebral Amyloid Angiopathy , 2010, Journal of neuropathology and experimental neurology.

[38]  H. Vinters,et al.  High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease. , 2010, Human pathology.

[39]  W. Freeman,et al.  Spontaneous Intracerebral Hemorrhage , 2010, Seminars in neurology.

[40]  C. Wessig,et al.  Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X. , 2010, Human molecular genetics.

[41]  A. Nath,et al.  Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. , 2010, The American journal of pathology.

[42]  S. Marks,et al.  Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis , 2010, Pediatric Nephrology.

[43]  E. V. Van Bockstaele,et al.  HIV-1 gp120-Induced Injury to the Blood-Brain Barrier: Role of Metalloproteinases 2 and 9 and Relationship to Oxidative Stress , 2010, Journal of neuropathology and experimental neurology.

[44]  Peter H Lin,et al.  HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells. , 2010, Cardiovascular research.

[45]  L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[46]  E. V. Bockstaele,et al.  Blood–brain barrier abnormalities caused by exposure to HIV-1 gp120 — Protection by gene delivery of antioxidant enzymes , 2010, Neurobiology of Disease.

[47]  H. Vinters,et al.  Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy , 2010, Brain pathology.

[48]  E. Mark Haacke,et al.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study , 2010, Acta Neuropathologica.

[49]  E. V. Bockstaele,et al.  HIV-1 gp120-induced neuroinflammation: Relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes , 2010, Experimental Neurology.

[50]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[51]  Honghong Yao,et al.  TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway , 2009, Cell Death and Differentiation.

[52]  Hidekazu Tomimoto,et al.  Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia , 2009, Neuroreport.

[53]  E. V. Bockstaele,et al.  HIV-1 gp120 neurotoxicity proximally and at a distance from the point of exposure: Protection by rSV40 delivery of antioxidant enzymes , 2009, Neurobiology of Disease.

[54]  M. Toborek,et al.  PPARα and PPARγ attenuate HIV‐induced dysrégulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  G. Plant,et al.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies , 2009, Acta Neuropathologica.

[56]  Honghong Yao,et al.  Involvement of TRPC Channels in CCL2-Mediated Neuroprotection against Tat Toxicity , 2009, The Journal of Neuroscience.

[57]  K. Martemyanov,et al.  Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death , 2008, The Journal of Neuroscience.

[58]  M. Toborek,et al.  Caveolin-1 Regulates Human Immunodeficiency Virus-1 Tat-Induced Alterations of Tight Junction Protein Expression via Modulation of the Ras Signaling , 2008, The Journal of Neuroscience.

[59]  Ulf Eriksson,et al.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.

[60]  Fredrik Lanner,et al.  Notch Signaling Regulates Platelet-Derived Growth Factor Receptor-β Expression in Vascular Smooth Muscle Cells , 2008, Circulation research.

[61]  M. Toborek,et al.  Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood–brain barrier , 2007, Brain Research.

[62]  E. V. Bockstaele,et al.  Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors , 2007, Gene Therapy.

[63]  J. Berman,et al.  Gap Junctions Mediate Human Immunodeficiency Virus-Bystander Killing in Astrocytes , 2007, The Journal of Neuroscience.

[64]  E. Masliah,et al.  Transgenic animal models of neurodegenerative diseases and their application to treatment development. , 2007, Advanced drug delivery reviews.

[65]  Keith A. Johnson,et al.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.

[66]  H. Vinters Imaging cerebral microvascular amyloid , 2007, Annals of neurology.

[67]  J. Geiger,et al.  Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-α-mediated neurotoxicity , 2007, Neurobiology of Disease.

[68]  Howard E Gendelman,et al.  HIV-1 gp120 Compromises Blood–Brain Barrier Integrity and Enhance Monocyte Migration across Blood–Brain Barrier: Implication for Viral Neuropathogenesis , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[69]  Shuxian Hu,et al.  Morphine stimulates CCL2 production by human neurons , 2006, Journal of Neuroinflammation.

[70]  E. V. Bockstaele,et al.  Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis , 2006, Gene Therapy.

[71]  Chris Zarow,et al.  Cognitive impact of subcortical vascular and Alzheimer's disease pathology , 2006, Annals of neurology.

[72]  M. di Luca,et al.  Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice , 2006, BMC Neuroscience.

[73]  O. Selnes,et al.  Vascular cognitive impairment , 2006, Nature Clinical Practice Neurology.

[74]  M. Toborek,et al.  HIV-TAT Protein Upregulates Expression of Multidrug Resistance Protein 1 in the Blood–Brain Barrier , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[75]  E. Englund,et al.  Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia , 2006, International journal of geriatric psychiatry.

[76]  H. Vinters,et al.  Effects of Anoxia and Hypoxia on Amyloid Precursor Protein Processing in Cerebral Microvascular Smooth Muscle Cells , 2006, Journal of neuropathology and experimental neurology.

[77]  Y. Matsumoto,et al.  Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis , 2006, Acta Neuropathologica.

[78]  G. Lammie,et al.  Hypertensive cerebral small vessel disease and stroke. , 2006, Brain pathology.

[79]  A. Nath,et al.  Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. , 2006, Neurotoxicology.

[80]  Mathias Jucker,et al.  Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models , 2006 .

[81]  M. Frosch,et al.  The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic , 2006 .

[82]  M. Jaskólski,et al.  The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models , 2006, Brain pathology.

[83]  T. Golde,et al.  Anti-Aβ42– and anti-Aβ40–specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model , 2005 .

[84]  A. Paetau,et al.  Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype , 2005, Neuropathology and applied neurobiology.

[85]  M. Toborek,et al.  Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[86]  John Hardy,et al.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. , 2005, The American journal of pathology.

[87]  Irene Otte-Höller,et al.  Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. , 2005, The American journal of pathology.

[88]  Chuanful Li,et al.  HIV-1 Tat protein-induced VCAM-1 expression in human pulmonary artery endothelial cells and its signaling. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[89]  Marlys Witte,et al.  Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells , 2005, Journal of NeuroVirology.

[90]  Brian J Bacskai,et al.  Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease , 2005, Journal of neuropathology and experimental neurology.

[91]  J. Hardy,et al.  Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice , 2005, Neuron.

[92]  J. Holton,et al.  Chromosome 13 dementias , 2005, Cellular and Molecular Life Sciences CMLS.

[93]  Donald W. Miller,et al.  Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. , 2005, Alcoholism, clinical and experimental research.

[94]  J. Reynolds,et al.  Cocaine Modulates Dendritic Cell-Specific C Type Intercellular Adhesion Molecule-3-Grabbing Nonintegrin Expression by Dendritic Cells in HIV-1 Patients1 , 2005, The Journal of Immunology.

[95]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[96]  P. Grammas,et al.  HIV-1 gp120 Proteins Alter Tight Junction Protein Expression and Brain Endothelial Cell Permeability: Implications for the Pathogenesis of HIV-Associated Dementia , 2005, Journal of neuropathology and experimental neurology.

[97]  W. Banks,et al.  HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells , 2005, Brain Research.

[98]  James L. Buescher,et al.  Overexpression of monocyte chemotactic protein-1/ CCL2 in β-amyloid precursor protein transgenic mice show accelerated diffuse β-amyloid deposition , 2005 .

[99]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.

[100]  S. Love,et al.  Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 2005 .

[101]  D. Dickson,et al.  Extracellular Deposits of Aβ Produced in Cultures of Alzheimer Disease Brain Vascular Smooth Muscle Cells , 2005 .

[102]  F. Schmitt,et al.  Neuroimaging correlates of HIV-associated BBB compromise , 2004, Journal of Neuroimmunology.

[103]  J. Bell,et al.  An update on the neuropathology of HIV in the HAART era , 2004, Histopathology.

[104]  B. Clurman,et al.  Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression , 2004, Molecular and Cellular Biology.

[105]  M. Mayo,et al.  Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. , 2004, The American journal of pathology.

[106]  J. Nicoll,et al.  Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage , 2004, The Lancet Neurology.

[107]  D. Antonetti,et al.  Regulation of tight junctions and loss of barrier function in pathophysiology. , 2004, The international journal of biochemistry & cell biology.

[108]  A. Beaudet,et al.  Morphine-Induced Changes in δ Opioid Receptor Trafficking Are Linked to Somatosensory Processing in the Rat Spinal Cord , 2004, The Journal of Neuroscience.

[109]  Eric E. Smith,et al.  Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage , 2004, Stroke.

[110]  R. Deane,et al.  Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein Precursor* , 2004, Journal of Biological Chemistry.

[111]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[112]  A. Karsan,et al.  Notch4 Inhibits Endothelial Apoptosis via RBP-Jκ-dependent and -independent Pathways* , 2004, Journal of Biological Chemistry.

[113]  K. Jellinger,et al.  Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology , 2004, Acta Neuropathologica.

[114]  J. Malter,et al.  Anti‐Aβ: The good, the bad, and the unforeseen , 2004 .

[115]  M. Frosch,et al.  Clinical manifestations of cerebral amyloid angiopathy–related inflammation , 2004, Annals of neurology.

[116]  K. Jellinger,et al.  Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study , 2004, Acta Neuropathologica.

[117]  J. Esteban,et al.  Living with the enemy: a physiological role for the β-amyloid peptide , 2004, Trends in Neurosciences.

[118]  I. Ferrer,et al.  Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease , 2004, Brain pathology.

[119]  O. Wiestler,et al.  Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.

[120]  K. Hinokuma,et al.  Subcortical hematoma caused by cerebral amyloid angiopathy: Does the first evidence of hemorrhage occur in the subarachnoid space? , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[121]  M. Wolfe,et al.  Identity and function of γ‐secretase , 2003 .

[122]  N. Hooper,et al.  ADAMs family members as amyloid precursor protein α‐secretases , 2003 .

[123]  Christina A. Wilson,et al.  Distinct presenilin‐dependent and presenilin‐independent γ‐secretases are responsible for total cellular Aβ production , 2003 .

[124]  Bernhard Hennig,et al.  HIV‐1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells , 2003, Journal of neuroscience research.

[125]  M. Verbeek,et al.  Pathogenesis of cerebral amyloid angiopathy , 2003, Brain Research Reviews.

[126]  D. Graham,et al.  Association Between Interleukin-1A Polymorphism and Cerebral Amyloid Angiopathy–Related Hemorrhage , 2003, Stroke.

[127]  A. Nath,et al.  Synaptic Transport of Human Immunodeficiency Virus-Tat Protein Causes Neurotoxicity and Gliosis in Rat Brain , 2003, The Journal of Neuroscience.

[128]  D. Holtzman,et al.  Matrix metalloproteinase–9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy , 2003, Annals of neurology.

[129]  G. Plant,et al.  Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View , 2003, Journal of neuropathology and experimental neurology.

[130]  R. Weller,et al.  A new role for astrocytes: β-amyloid homeostasis and degradation , 2003 .

[131]  G. Mckhann,et al.  Clinicopathological review: primary angiitis of the central nervous system in association with cerebral amyloid angiopathy. , 2003, Neurosurgery.

[132]  M. Yamada,et al.  Association of neprilysin polymorphism with cerebral amyloid angiopathy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[133]  J. Frackowiak,et al.  Secretion and Accumulation of Aβ by Brain Vascular Smooth Muscle Cells from AβPP‐Swedish Transgenic Mice , 2003 .

[134]  W. V. Van Nostrand,et al.  Pathogenic Aβ induces the expression and activation of matrix metalloproteinase‐2 in human cerebrovascular smooth muscle cells , 2003 .

[135]  F. Scaravilli,et al.  The Changing Pattern of HIV Neuropathology in the HAART Era , 2003, Journal of neuropathology and experimental neurology.

[136]  N. Sacktor,et al.  Human immunodeficiency virus-associated dementia: An evolving disease , 2003, Journal of NeuroVirology.

[137]  H. Vinters,et al.  Smooth muscle cells and the pathogenesis of cerebral microvascular disease ("angiomyopathies"). , 2003, Experimental and molecular pathology.

[138]  C. Holmes,et al.  Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.

[139]  R. Ransohoff,et al.  The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). , 2003, Seminars in immunology.

[140]  Yong Woo Lee,et al.  HIV‐Tat protein induces oxidative and inflammatory pathways in brain endothelium , 2002, Journal of neurochemistry.

[141]  E. Masliah,et al.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis , 2002, Neurology.

[142]  M. Staufenbiel,et al.  Cerebral Hemorrhage After Passive Anti-Aβ Immunotherapy , 2002, Science.

[143]  S. D. Preston,et al.  Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain , 2002 .

[144]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[145]  Ulf Eriksson,et al.  Angiogenesis stimulated by PDGF‐CC, a novel member in the PDGF family, involves activation of PDGFR‐aa and ‐ap receptors , 2002 .

[146]  M. Marcinkiewicz,et al.  Declining Expression of Neprilysin in Alzheimer Disease Vasculature: Possible Involvement in Cerebral Amyloid Angiopathy , 2002, Journal of neuropathology and experimental neurology.

[147]  R. Nitsch,et al.  Aβ42-induced Increase in Neprilysin Is Associated with Prevention of Amyloid Plaque Formation in Vivo * , 2002, The Journal of Biological Chemistry.

[148]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[149]  H. Vinters,et al.  Tissue Microarrays in the Study of Non‐Neoplastic Disease of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[150]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[151]  Hartwig Wolburg,et al.  Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.

[152]  H. Vinters,et al.  Hypoxia and reoxygenation of brain microvascular smooth muscle cells in vitro: cellular responses and expression of cerebral amyloid angiopathy‐associated proteins , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[153]  E. Major,et al.  HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology. , 2002, Microbes and infection.

[154]  H. Braak,et al.  Two Types of Sporadic Cerebral Amyloid Angiopathy , 2002, Journal of neuropathology and experimental neurology.

[155]  Taku Sugawara,et al.  Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood–Brain Barrier Disruption after Transient Focal Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[156]  R. Roos,et al.  Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles , 2001, Annals of neurology.

[157]  Yong Woo Lee,et al.  Cocaine activates redox-regulated transcription factors and induces TNF-α expression in human brain endothelial cells , 2001, Brain Research.

[158]  M. Wolfe,et al.  A Portrait of Alzheimer Secretases--New Features and Familiar Faces , 2001, Science.

[159]  D. Markovitz,et al.  Human Immunodeficiency Virus Type 1 (HIV-1)-Induced GRO-α Production Stimulates HIV-1 Replication in Macrophages and T Lymphocytes , 2001, Journal of Virology.

[160]  T. Grabowski,et al.  Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.

[161]  A. Lackner,et al.  Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques , 2001, The Journal of experimental medicine.

[162]  M. Staufenbiel,et al.  Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.

[163]  S. Greenberg,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[164]  W. Jagust,et al.  Neuropathologic Substrates of Ischemic Vascular Dementia , 2000, Journal of neuropathology and experimental neurology.

[165]  A. Bansal,et al.  Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum , 2000, Brain Research.

[166]  Andreas Hufnagel,et al.  Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[167]  R. A. Frommelt,et al.  Cerebral Beta Amyloid Angiopathy Is a Risk Factor for Cerebral Ischemic Infarction. A Case Control Study in Human Brain Biopsies , 2000, Journal of neuropathology and experimental neurology.

[168]  A. Fagan,et al.  Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model , 2000, Annals of neurology.

[169]  L. Thal,et al.  Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. , 2000, Archives of neurology.

[170]  S. D. House,et al.  Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. , 2000, Life sciences.

[171]  I. Tesseur,et al.  Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons , 2000, Neurobiology of Aging.

[172]  B. Urmoneit,et al.  Apolipoprotein E, Smooth Muscle Cells and the Pathogenesis of Cerebral Amyloid Angiopathy: the Potential Role of Impaired Cerebrovascular Aβ Clearance , 2000, Annals of the New York Academy of Sciences.

[173]  H. Vinters,et al.  Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. , 2000, Stroke.

[174]  Melina V Jones,et al.  Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine , 2000, Annals of neurology.

[175]  J. Christman,et al.  Redox Regulation of Nuclear Factor Kappa B: Therapeutic Potential for Attenuating Inflammatory Responses , 2000, Brain pathology.

[176]  O. Finco,et al.  Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. , 1999, AIDS.

[177]  C. Achim,et al.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[178]  P. Cheney,et al.  Microglial Activation and Neurological Symptoms in the SIV Model of NeuroAIDS: Association of MHC-II and MMP-9 Expression with Behavioral Deficits and Evoked Potential Changes , 1999, Neurobiology of Disease.

[179]  B. Sommer,et al.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[180]  A. Nath,et al.  Involvement of Inositol 1,4,5‐Trisphosphate‐Regulated Stores of Intracellular Calcium in Calcium Dysregulation and Neuron Cell Death Caused by HIV‐1 Protein Tat , 1999, Journal of neurochemistry.

[181]  M. Fujimura,et al.  Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[182]  S. Love,et al.  Cerebral Amyloid Angiopathy–Related Hemorrhage Interaction of APOE ε2 With Putative Clinical Risk Factors , 1999 .

[183]  M. Didier-Bazès,et al.  Spatiotemporal Expression Patterns of Metalloproteinases and Their Inhibitors in the Postnatal Developing Rat Cerebellum , 1999, The Journal of Neuroscience.

[184]  L Zhang,et al.  Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. , 1999, Clinical immunology.

[185]  S. Croul,et al.  Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.

[186]  S. L. Chang,et al.  Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. , 1998, Clinical immunology and immunopathology.

[187]  G. Rosenberg,et al.  Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. , 1998, Stroke.

[188]  S. Greenberg,et al.  Cerebral amyloid angiopathy , 1998, Neurology.

[189]  S. Greenberg,et al.  Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy , 1998, Neurology.

[190]  R. Roos,et al.  Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D) , 1998, Acta Neuropathologica.

[191]  W. V. Van Nostrand,et al.  Pathologic Amyloid β‐Protein Cell Surface Fibril Assembly on Cultured Human Cerebrovascular Smooth Muscle Cells , 1998 .

[192]  L. Mucke,et al.  Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease , 1997, Nature.

[193]  L. Walker,et al.  Animal models of cerebral β-amyloid angiopathy , 1997, Brain Research Reviews.

[194]  O. Finco,et al.  Induction of CD4+ T cell depletion in mice doubly transgenic for HIV gp120 and human CD4 , 1997, European journal of immunology.

[195]  D. Graham,et al.  High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy , 1997, Annals of neurology.

[196]  D. Harrison,et al.  Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.

[197]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[198]  M. Yamada,et al.  Immune reactions associated with cerebral amyloid angiopathy. , 1996, Stroke.

[199]  L. Thal,et al.  Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease , 1996, Neurology.

[200]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[201]  Gary A. Rosenberg,et al.  Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[202]  H. Vinters,et al.  Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease , 1996, Brain pathology.

[203]  J. Davis-Salinas,et al.  Amyloid β‐Protein Induces the Cerebrovascular Cellular Pathology of Alzheimer's Disease and Related Disorders a , 1996 .

[204]  N. Fountain,et al.  Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 1996, Neurology.

[205]  W. V. Van Nostrand,et al.  Amyloid β-Protein Aggregation Nullifies Its Pathologic Properties in Cultured Cerebrovascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[206]  C. Cotman,et al.  Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells , 1995 .

[207]  L. Thal,et al.  Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.

[208]  H. Wiśniewski,et al.  Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs , 1995, Brain Research.

[209]  H. Wiśniewski,et al.  Non‐Fibrillar β‐Amyloid Protein is Associated with Smooth Muscle Cells of Vessel Walls in Alzheimer Disease , 1994, Journal of neuropathology and experimental neurology.

[210]  H. Vinters,et al.  Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. , 1994, Ultrastructural Pathology.

[211]  N. Morisaki,et al.  Migratory and proliferative effect of platelet‐derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet‐derived growth factor , 1994, Journal of cellular physiology.

[212]  P. Stewart,et al.  Re‐evaluating the role of astrocytes in blood‐brain barrier induction , 1993, Developmental Dynamics.

[213]  R. Ransohoff,et al.  Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[214]  H. Vinters,et al.  A morphometric study of the blood-brain barrier in Alzheimer's disease. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[215]  J. Vonsattel,et al.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.

[216]  C. Masters,et al.  Surgical risk of hemorrhage in cerebral amyloid angiopathy. , 1991, Stroke.

[217]  H. Vinters,et al.  Cerebral amyloid angiopathy and granulomatous angiitis: immunohistochemical study using antibodies to the Alzheimer A4 peptide. , 1990, Human pathology.

[218]  H. Vinters,et al.  Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. , 1990, The American journal of pathology.

[219]  D. Ramsay,et al.  Fatal Streptokinase-Induced Intracerebral Haemorrhage in Cerebral Amyloid Angiopathy , 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[220]  M. Brightman,et al.  Development of membrane interactions between brain endothelial cells and astrocytes in vitro , 1988, International Journal of Developmental Neuroscience.

[221]  G. Lutty,et al.  Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[222]  G. Goldstein,et al.  Endothelial Cell‐Astrocyte Interactions , 1988, Annals of the New York Academy of Sciences.

[223]  C. Bergeron,et al.  Amyloid Angiopathy in Alzheimer's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[224]  Z. Nagy,et al.  Tight junctions of brain endothelium in vitro are enhanced by astroglia , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[225]  H. Vinters Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[226]  M. Hirsch,et al.  Immunohistochemical identification of HTLV‐III antigen in brains of patients with AIDS , 1986, Annals of neurology.

[227]  T. Mandybur Cerebral Amyloid Angiopathy: The Vascular Pathology and Complications , 1986, Journal of neuropathology and experimental neurology.

[228]  J. Girvin,et al.  Isolation and culture of cells derived from human cerebral microvessels , 1985, Cell and Tissue Research.

[229]  S. Weiss,et al.  Oxidative autoactivation of latent collagenase by human neutrophils. , 1985, Science.

[230]  A. Sima,et al.  The Value of Histopathological Examination of Surgically Removed Blood Clot in Determining the Etiology of Spontaneous Intracerebral Hemorrhagef , 1984, Stroke.

[231]  H. Vinters,et al.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. , 1983, Stroke.

[232]  H. Vinters,et al.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. , 1983, Stroke.

[233]  K. Jellinger,et al.  Cerebrovascular amyloidosis with cerebral hemorrhage , 1977, Journal of Neurology.

[234]  Rodney A. Bales,et al.  Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia , 2011, Journal of NeuroVirology.

[235]  S. Nag Morphology and properties of astrocytes. , 2011, Methods in molecular biology.

[236]  Yaakov Stern,et al.  HIV-associated cognitive impairment before and after the advent of combination therapy , 2011, Journal of NeuroVirology.

[237]  K. Jellinger The pathology of "vascular dementia": a critical update. , 2008, Journal of Alzheimer's disease : JAD.

[238]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[239]  C. Iadecola,et al.  Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. , 2006, Journal of applied physiology.

[240]  A. Palsdottir,et al.  Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects. , 2006, Brain pathology.

[241]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[242]  M. Rossor,et al.  NEUROLOGICAL INFECTION AND INFLAMMATION , 2004, Journal of Neurology Neurosurgery & Psychiatry.

[243]  M. Viitanen,et al.  The Neuropathology of Dementia: Vascular dementias , 2004 .

[244]  H. Vinters,et al.  Neuropathologic Features and Grading of Alzheimer-Related and Sporadic CAA , 2000 .

[245]  L. Mucke,et al.  Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. , 2000, The American journal of pathology.

[246]  J. Tekstra,et al.  Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. , 1999, The American journal of pathology.

[247]  D. Taub,et al.  Cocaine opens the blood-brain barrier to HIV-1 invasion. , 1998, Journal of neurovirology.

[248]  S. D. House,et al.  Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? , 1998, Advances in experimental medicine and biology.